Membranous Nephropathy
📧 Sign up to get email alerts when something new happens for Membranous Nephropathy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-06-03Clinical Trial Update: A Study to Examine the Efficacy and Safety of Zanubrutinib Given to Adults With Primary Membranous Nephropathy [Phase 2, Phase 3]
A Phase 2/3 clinical trial evaluating the efficacy and safety of zanubrutinib in adults with primary membranous nephropathy is active but no…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Evaluation of Efficacy, Safety, and Tolerability of Povetacicept in Participants With Primary Membranous Nephropathy (pMN) [Phase 2, Phase 3]
Clinical trial update for povetacicept in primary membranous nephropathy, currently recruiting in Phase 2/3 to evaluate efficacy, safety, an…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Primary Membranous Nephropathy (PMN) [Phase 3]
A Phase 3 clinical trial is evaluating felzartamab infusions in adults with primary membranous nephropathy, and is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: A Clinical Study Evaluating the Safety and Efficacy of GT719 Universal Cell Injection in the Treatment of Immune-mediated Kidney Diseases [EARLY_Phase 1]
An early Phase 1 clinical study evaluating the safety and efficacy of GT719 universal cell injection for immune-mediated kidney diseases is …
-
CLINICAL_TRIALS trial_result · 2026-04-22Clinical Trial Update: Study of ALXN1920 in Adult Participants With Primary Membranous Nephropathy (PMN) [Phase 2]
A Phase 2 clinical trial of ALXN1920 in adults with primary membranous nephropathy is currently recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: A Phase 2 Study of Budoprutug in Subjects With Primary Membranous Nephropathy [Phase 2]
A Phase 2 clinical trial evaluating Budoprutug for primary membranous nephropathy is currently recruiting, sponsored by Climb Bio, Inc.
-
CLINICAL_TRIALS trial_result · 2026-04-16Clinical Trial Update: Efficacy and Safety of CD19 CAR-γδ T Cells in the Treatment of Relapsed/Refractory Autoimmune Nephropathy [EARLY_Phase 1]
Clinical trial update for a Phase 1 study of CD19 CAR-γδ T cells in relapsed/refractory autoimmune nephropathy, targeting membranous nephrop…
-
CLINICAL_TRIALS trial_result · 2026-04-08Clinical Trial Update: SLIT ABS: Study on Patients With Autoimmune Podocytopathy [NA]
This clinical trial update indicates the SLIT ABS study for autoimmune podocytopathy is currently recruiting, sponsored by Meyer Children's …
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Efficacy and Safety of Finerenone in Patients With Primary Membranous Nephropathy [Phase 4]
A Phase 4 clinical trial evaluating the efficacy and safety of finerenone in patients with primary membranous nephropathy is currently recru…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: A Study Evaluating the Efficacy and Safety of Obinutuzumab in Participants With Primary Membranous Nephropathy [Phase 3]
A Phase 3 clinical trial evaluating obinutuzumab for primary membranous nephropathy is underway and currently active but not recruiting.
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: Study of WAL0921 in Patients With Glomerular Kidney Diseases [Phase 2]
Walden Biosciences reports a Phase 2 clinical trial of WAL0921 in multiple glomerular diseases, currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-03-30Clinical Trial Update: Safety Study of IgAN, LN, MN, & C3 Glomerulopathy Including Dense Deposit Disease Treated With OMS721 [Phase 2]
Omeros' Phase 2 safety study of OMS721 in immunoglobulin A nephropathy, lupus nephritis, membranous nephropathy, and C3 glomerulopathy inclu…
-
CLINICAL_TRIALS trial_result · 2026-03-24Clinical Trial Update: In Vitro Immunomodulation in Membranous Nephropathy Relapses [NA]
A clinical trial investigating in vitro immunomodulation in membranous nephropathy relapses has completed.
-
CLINICAL_TRIALS research · 2026-03-24Clinical Trial Update: Role of Anti-mouse PLA2R1 ELISA in Membranous Nephropathy [NA]
A completed clinical trial evaluating the role of the anti-mouse PLA2R1 ELISA in membranous nephropathy.
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: An Outcome Analysis of Primary Membranous Nephropathy
Clinical trial update detailing an outcome analysis for primary membranous nephropathy; the study is currently recruiting and sponsored by t…
-
CLINICAL_TRIALS trial_result · 2026-03-20Clinical Trial Update: Effect of B-cell Depleting Therapies on PLA2R-specific B Cells in Patients With Membranous Nephropathy [NA]
A completed clinical trial update examining how B-cell depleting therapies affect PLA2R-specific B cells in patients with membranous nephrop…
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: Autoreactive B Cells in Membranous Nephropathy
A clinical trial is investigating autoreactive B cells in membranous nephropathy and is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-09Clinical Trial Update: A Phase 1/2 Study of NKX019 in Subjects With Autoimmune Disease (Ntrust-1) [Phase 1, Phase 2]
Nkarta, Inc. is conducting a Phase 1/2 study of NKX019 for autoimmune diseases and is currently recruiting. The trial targets lupus nephriti…
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: A Study to Examine the Efficacy and Safety of Zanubrutinib Given to Adults With Primary Membranous Nephropathy [Phase 2, Phase 3]
A Phase 2/3 clinical trial is evaluating zanubrutinib for adults with primary membranous nephropathy to assess its efficacy and safety; the …
-
CLINICAL_TRIALS trial_result · 2026-03-03Clinical Trial Update: Analysis of T- and B-Cell Subpopulations in Membranous Nephropathy
Completed clinical trial analyzing T- and B-cell subpopulations in membranous nephropathy, including PLA2R-induced and THSD7A-induced subtyp…
-
CLINICAL_TRIALS research · 2026-02-18Clinical Trial Update: Omics of Rituximab-resistance
A clinical trial update describes an omics study investigating Rituximab resistance in membranous nephropathy, sponsored by Mario Negri Inst…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: NEPTUNE Match Study [NA]
The NEPTUNE Match Study is currently recruiting, focusing on nephrotic syndrome in children and related glomerular diseases such as focal se…
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: Belimumab With Rituximab for Primary Membranous Nephropathy [Phase 2]
Phase 2 clinical trial evaluating the combination of belimumab with rituximab for primary membranous nephropathy is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-02-12Clinical Trial Update: Efficacy and Safety of VB119 in Subjects With Membranous Nephropathy [Phase 1, Phase 2]
The update reports on the efficacy and safety of VB119 in membranous nephropathy across Phase 1/2, but the trial was terminated.
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: A Phase I Study of YK012 in Primary Membranous Nephropathy [Phase 1]
Phase I clinical trial of YK012 for primary membranous nephropathy; the study is not yet recruiting.